DBV Technologies S.A. (DBVT) stock
DBVTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as DBVTF
$11.43−0.45 (-3.79%)
Close on Nov 12, 2026Market cap $718.69MP/E –Yield –
DBV Technologies enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
DBV Technologies's enterprise value was $505.79M on Nov 10, 2026, against $288.80M a year earlier. Over the last 5 years it ranged from -$212.88M to $642.40M, with a median of -$47.87M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 10, 2026 | $505.79M | +11.1% |
| 2025 | Dec 31, 2025 | $455.36M | +3407.1% |
| 2024 | Dec 31, 2024 | $12.98M | – |
| 2023 | Dec 29, 2023 | -$113.06M | – |
| 2022 | Dec 30, 2022 | -$171.39M | – |
| 2021 | Dec 31, 2021 | -$63.07M | – |
| 2020 | Dec 31, 2020 | -$142.51M | – |
| 2019 | Dec 31, 2019 | -$11.50M | -117.9% |
| 2018 | Dec 31, 2018 | $64.18M | -73.3% |
| 2017 | Dec 29, 2017 | $240.64M | -20.4% |
| 2016 | Dec 30, 2016 | $302.43M | – |
See a number that looks wrong?